Pfizer Demands Bank Reserves, Military Bases & Embassy Buildings As Collateral For COVID-19 Vaccines [VIDEO]

ER Editor:  GreatGameIndia has drawn its reporting from India’s WIONews’ report, which we recommend. See How Pfizer tried to bully Argentina and Brazil in exchange for vaccines.
.
Readers may also be interested in this piece from Pharmaceutical Technology titled Pfizer accused of ‘bullying’ Latin American countries during vaccine negotiations.
.
Original reporting for this story comes from The Bureau of Investigative Journalism. See its report, ‘Held to ransom’: Pfizer demands governments gamble with state assets to secure vaccine deal. This reporting first broke on February 23, 2021.
.
We recommend viewing the video from WION below.
********

Pfizer Demanding Bank Reserves, Military Bases And Embassy Buildings As Collateral For COVID-19 Vaccines

GREATGAMEINDIA

Pharma giant Pfizer has been holding sovereign governments to ransom, making bizarre demands asking for bank reserves, embassy buildings and military bases as collateral in return for COVID-19 vaccines.

Pfizer Demanding Bank Reserves, Military Bases And Embassy Buildings As Collateral For COVID-19 Vaccines

The US-based company Pfizer is holding governments to ransom, interfering with their legislation, and even demanding military bases as guarantee.

Pfizer asked the Govt of Argentina to be compensated for the cost of any future civil lawsuits, reported WION.

If someone files a civil lawsuit against Pfizer in Argentina and wins that case, the government of Argentina and not Pfizer would pay the compensation.

So, Argentina’s parliament passed a new law in October 2020, but Pfizer was unhappy with its phrasing.

The law said Pfizer needs to at least pay for negligence, for its own mistakes if it happens to make any in the future.

Pfizer rejected this, after which Argentina offered to amend the law to define negligence more clearly – to include only vaccine distribution and delivery under negligence.

Pfizer was still not happy and demanded the law be amended through a new decree, which Argentina refused.

Pfizer then asked Argentina to buy an international insurance to pay for potential future cases against Pfizer, to which the country agreed.

But that was not enough, in December 2020, Pfizer again came back with more demands.

And this time Pfizer demanded Argentina’s sovereign assets as collateral.

Pfizer demanded that Argentina put its bank reserves, military bases and embassy buildings at stake.

Argentina did not agree with Pfizer’s demands.

Another country Pfizer made such bizarre demands is with Brazil.

Pfizer told the Govt of Brazil to create a guarantee fund, and deposit money in a foreign bank account.

On January 23, 2021 – Brazil’s Health Ministry put out a statement citing excerpts from Pfizer’s pre-contract clauses.

Here’s a list of Pfizer’s demands:

  • Brazil waives the sovereignty of its assets abroad in favour of Pfizer,
  • that the rules of the land be not applied to Pfizer,
  • that Brazil take into consideration a delay in delivery,
  • that Pfizer is not penalised for a delayed delivery, and
  • that in case of any side effects, Pfizer be exempted from all civil liability.

The government of Brazil calls these clauses abusive. The Pfizer deal with Brazil failed too.

Pfizer even wanted India to order its COVID-19 vaccines without any local trials.

According to the co-founder of BioNTech Dr Ugur Sahin, the COVID-19 vaccine he designed for Pfizer was designed in just few hours in a single day on January 25, 2020. No other vaccine in history has been created and manufactured so quickly. Previously, the fastest vaccine ever developed took more than four years.

As reported by GreatGameIndia earlier, Pfizer has paid $2.3 billion in the largest healthcare fraud settlement in history to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products.

Even, the US government paid over $57 million in compensation for vaccine injuries and deaths till March 2020 alone.

************

Source

••••

The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)

••••

Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.

••••

Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.

••••

Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.


*